sympatholytics ( including methyldopa and reserpine ) , converting enzyme inhibitors ( captopril and enalapril ) , and calcium entry blockers led to significant regression of left ventricular hypertrophy .
C0014025
enalapril
C0149721
left ventricular hypertrophy